Drawing for VASTOLA

USPTO serial 88519128

VASTOLA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ONUOHA, UKACHUKWU FREDERICK
Law office
TMO LAW OFFICE 121 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with VASTOLA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stephen R. Barrese, Esq.

STEPHEN R. BARRESE, ESQ. DILWORTH & BARRESE, LLP1000 WOODBURY ROAD SUITE 405WOODBURY, NY 11797UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations for the treatment of inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue; Ophthalmic preparations; Ocular pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Nov 5, 2020MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 5, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 22, 2020GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Apr 22, 2020GNSIINQUIRY TO SUSPENSION E-MAILED—
Apr 22, 2020CNSISUSPENSION INQUIRY WRITTEN—
Oct 3, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 3, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Oct 3, 2019CNSLSUSPENSION LETTER WRITTEN—
Oct 3, 2019DOCKASSIGNED TO EXAMINER—
Jul 24, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 20, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance